Capstan Therapeutics
Clinical trials sponsored by Capstan Therapeutics, explained in plain language.
Now part of
AbbVie Inc.
ABBV
NYSE
A biotechnology company developing targeted cell therapies using mRNA and CAR-T technology.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.